Annual FCF
-$33.64 M
-$7.93 M-30.83%
December 31, 2023
Summary
- As of February 8, 2025, PDSB annual free cash flow is -$33.64 million, with the most recent change of -$7.93 million (-30.83%) on December 31, 2023.
- During the last 3 years, PDSB annual FCF has fallen by -$20.49 million (-155.81%).
- PDSB annual FCF is now -311.11% below its all-time high of -$8.18 million, reached on December 31, 2013.
Performance
PDSB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$8.00 M
+$887.20 K+9.98%
September 30, 2024
Summary
- As of February 8, 2025, PDSB quarterly free cash flow is -$8.00 million, with the most recent change of +$887.20 thousand (+9.98%) on September 30, 2024.
- Over the past year, PDSB quarterly FCF has increased by +$457.50 thousand (+5.41%).
- PDSB quarterly FCF is now -945.46% below its all-time high of $946.20 thousand, reached on June 30, 2021.
Performance
PDSB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$35.28 M
-$823.80 K-2.39%
September 30, 2024
Summary
- As of February 8, 2025, PDSB TTM free cash flow is -$35.28 million, with the most recent change of -$823.80 thousand (-2.39%) on September 30, 2024.
- Over the past year, PDSB TTM FCF has dropped by -$1.65 million (-4.89%).
- PDSB TTM FCF is now -710.88% below its all-time high of -$4.35 million, reached on March 31, 2015.
Performance
PDSB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
PDSB Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.8% | +5.4% | -4.9% |
| 3 y3 years | -155.8% | -66.2% | -12.3% |
| 5 y5 years | -1.5% | -66.2% | -12.3% |
PDSB Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -169.4% | at low | -77.7% | +39.3% | -182.6% | at low |
| 5 y | 5-year | -169.4% | at low | -945.5% | +39.3% | -303.8% | at low |
| alltime | all time | -311.1% | +17.7% | -945.5% | +74.9% | -710.9% | +20.6% |
PDS Biotechnology Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.00 M(-10.0%) | -$35.28 M(+2.4%) |
| Jun 2024 | - | -$8.89 M(-10.6%) | -$34.46 M(+13.4%) |
| Mar 2024 | - | -$9.94 M(+17.5%) | -$30.39 M(-9.7%) |
| Dec 2023 | -$33.64 M(+30.8%) | -$8.46 M(+17.9%) | -$33.64 M(+2.8%) |
| Sep 2023 | - | -$7.18 M(+49.1%) | -$32.71 M(+4.1%) |
| Jun 2023 | - | -$4.81 M(-63.5%) | -$31.42 M(-3.4%) |
| Mar 2023 | - | -$13.19 M(+75.2%) | -$32.53 M(+26.5%) |
| Dec 2022 | -$25.71 M(+105.9%) | -$7.53 M(+27.8%) | -$25.71 M(+13.3%) |
| Sep 2022 | - | -$5.89 M(-0.4%) | -$22.68 M(+3.5%) |
| Jun 2022 | - | -$5.92 M(-7.1%) | -$21.92 M(+45.6%) |
| Mar 2022 | - | -$6.37 M(+41.5%) | -$15.05 M(+20.6%) |
| Dec 2021 | -$12.49 M(-5.0%) | -$4.50 M(-12.2%) | -$12.49 M(-1.0%) |
| Sep 2021 | - | -$5.13 M(-642.0%) | -$12.61 M(+44.4%) |
| Jun 2021 | - | $946.20 K(-124.9%) | -$8.74 M(-36.6%) |
| Mar 2021 | - | -$3.80 M(-17.9%) | -$13.79 M(+4.9%) |
| Dec 2020 | -$13.15 M(-27.2%) | -$4.63 M(+269.7%) | -$13.15 M(-6.3%) |
| Sep 2020 | - | -$1.25 M(-69.5%) | -$14.04 M(-18.0%) |
| Jun 2020 | - | -$4.10 M(+29.7%) | -$17.12 M(-4.2%) |
| Mar 2020 | - | -$3.16 M(-42.7%) | -$17.87 M(-1.1%) |
| Dec 2019 | -$18.07 M | -$5.52 M(+27.6%) | -$18.07 M(-59.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$4.33 M(-10.9%) | -$44.45 M(+9.6%) |
| Jun 2019 | - | -$4.86 M(+44.3%) | -$40.56 M(+12.3%) |
| Mar 2019 | - | -$3.37 M(-89.4%) | -$36.12 M(+8.9%) |
| Dec 2018 | -$33.15 M(-18.9%) | -$31.90 M(+7281.1%) | -$33.15 M(+215.1%) |
| Sep 2018 | - | -$432.20 K(+4.0%) | -$10.52 M(-51.2%) |
| Jun 2018 | - | -$415.40 K(+2.7%) | -$21.54 M(-29.2%) |
| Mar 2018 | - | -$404.30 K(-95.6%) | -$30.43 M(-25.6%) |
| Dec 2017 | -$40.89 M(+24.4%) | -$9.27 M(-19.1%) | -$40.89 M(+7.6%) |
| Sep 2017 | - | -$11.45 M(+23.2%) | -$38.01 M(+7.1%) |
| Jun 2017 | - | -$9.30 M(-14.4%) | -$35.49 M(+2.6%) |
| Mar 2017 | - | -$10.86 M(+69.9%) | -$34.59 M(+5.2%) |
| Dec 2016 | -$32.88 M(+42.6%) | -$6.39 M(-28.5%) | -$32.88 M(-2.6%) |
| Sep 2016 | - | -$8.94 M(+6.5%) | -$33.77 M(+11.9%) |
| Jun 2016 | - | -$8.39 M(-8.3%) | -$30.18 M(+8.4%) |
| Mar 2016 | - | -$9.15 M(+25.6%) | -$27.86 M(+20.8%) |
| Dec 2015 | -$23.06 M(+117.5%) | -$7.29 M(+36.2%) | -$23.06 M(+46.2%) |
| Sep 2015 | - | -$5.35 M(-11.8%) | -$15.77 M(+51.4%) |
| Jun 2015 | - | -$6.07 M(+39.4%) | -$10.42 M(+139.4%) |
| Mar 2015 | - | -$4.35 M | -$4.35 M |
| Dec 2014 | -$10.60 M(+29.6%) | - | - |
| Dec 2013 | -$8.18 M | - | - |
FAQ
- What is PDS Biotechnology annual free cash flow?
- What is the all time high annual FCF for PDS Biotechnology?
- What is PDS Biotechnology annual FCF year-on-year change?
- What is PDS Biotechnology quarterly free cash flow?
- What is the all time high quarterly FCF for PDS Biotechnology?
- What is PDS Biotechnology quarterly FCF year-on-year change?
- What is PDS Biotechnology TTM free cash flow?
- What is the all time high TTM FCF for PDS Biotechnology?
- What is PDS Biotechnology TTM FCF year-on-year change?
What is PDS Biotechnology annual free cash flow?
The current annual FCF of PDSB is -$33.64 M
What is the all time high annual FCF for PDS Biotechnology?
PDS Biotechnology all-time high annual free cash flow is -$8.18 M
What is PDS Biotechnology annual FCF year-on-year change?
Over the past year, PDSB annual free cash flow has changed by -$7.93 M (-30.83%)
What is PDS Biotechnology quarterly free cash flow?
The current quarterly FCF of PDSB is -$8.00 M
What is the all time high quarterly FCF for PDS Biotechnology?
PDS Biotechnology all-time high quarterly free cash flow is $946.20 K
What is PDS Biotechnology quarterly FCF year-on-year change?
Over the past year, PDSB quarterly free cash flow has changed by +$457.50 K (+5.41%)
What is PDS Biotechnology TTM free cash flow?
The current TTM FCF of PDSB is -$35.28 M
What is the all time high TTM FCF for PDS Biotechnology?
PDS Biotechnology all-time high TTM free cash flow is -$4.35 M
What is PDS Biotechnology TTM FCF year-on-year change?
Over the past year, PDSB TTM free cash flow has changed by -$1.65 M (-4.89%)